Journal
CLINICAL CANCER RESEARCH
Volume 21, Issue 14, Pages 3121-3130Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1078-0432.CCR-14-1189
Keywords
-
Categories
Funding
- Altman Goldstein Discovery Fellowship
- Ovarian Cancer Research Fund
- Foundation for Women's Cancer
- Cancer Prevention Research Institute of Texas (CPRIT) [RP101502, RP101489, RP110595]
- NIH [U54CA151668, P50CA083639, CA109298, P50CA098258, UH2TR000943, CA016672, U54CA96300, U54CA96297]
- CPRIT [RP110595, RP120214]
- Ovarian Cancer Research Fund Program Project Development Grant
- U.S. Department of Defense [OC120547, OC093416]
- Betty Ann Asche Murray Distinguished Professorship
- RGK Foundation
- Gilder Foundation
- Judi A. Rees Ovarian Cancer Research Fund
- Chapman Foundation
- Meyer and Ida Gordon Foundation
- Blanton-Davis Ovarian Cancer Research Program
Ask authors/readers for more resources
Recent advances in nanotechnology have established its importance in several areas including medicine. The myriad of applications in oncology range from detection and diagnosis to drug delivery and treatment. Although nanotechnology has attracted a lot of attention, the practical application of nanotechnology to clinical cancer care is still in its infancy. This review summarizes the role that nanotechnology has played in improving cancer therapy, its potential for affecting all aspects of cancer care, and the challenges that must be overcome to realize its full promise. (C) 2015 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
